Stroke Trial, Recruiting NCT06852209 Sponsor: University Hospital, Bordeaux Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT06852209
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Men or women aged 18 to 74 years old
  • People who are right-handed
  • People who have had their first-ever ischemic stroke (a stroke caused by a blocked blood vessel), confirmed by a brain MRI scan, within the past 3 to 6 months
  • People who still have cognitive (thinking or memory) difficulties at least 3 months after their stroke, measured by a standard memory and thinking test called the MoCA, with the score threshold depending on how many years of education the person completed
  • People whose thinking difficulties affect at least one of these areas: planning and organising (executive functions), attention, or how quickly the brain processes information
  • People whose stroke occurred in a specific area of the brain (the middle cerebral artery territory and/or the basal ganglia/thalamus regions)
  • People with only mild stroke-related disability, with no significant speech difficulties or severe vision problems that would interfere with study tasks
  • People who had little to no disability before their stroke, based on a standard disability scale
  • Women who could become pregnant must be using effective contraception and have a negative pregnancy test
  • People who are covered by French Social Insurance
  • People who have given written consent to participate

Who may not be able to join:

  • People who had thinking or memory problems before their stroke
  • People with a history of a psychiatric (mental health) disorder
  • People currently taking psychiatric or mood-related medications (psychotropic medications)
  • People who cannot have an MRI scan (for example, due to a pacemaker or metal implants)
  • People who are pregnant or breastfeeding
  • People with a long-term illness that would make it difficult to attend all study visits for the full duration of the trial
  • People who are not fluent French speakers
  • People who are under legal protection (confirm with trial site)
  • People who are unable to give their own personal consent to participate
  • People in an emergency medical situation
  • People whose first required MRI scan was incomplete, not done, or could not be assessed

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sharmila SAGNIER, University Hospital, Bordeaux

Phone: 05 56 79 55 20

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
28 February 2025
Est. completion
28 October 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Differential CEN-DMN activity and imaging contrast between regulation and rest

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov